Description
As you know, I'm very passionate about my dermatology and, although I finished practising, I still keep a keen interest in derm developments such as the release of cytopoint, our new monoclonal antibody against IL31.
As you know, I'm very passionate about my dermatology and, although I finished practising, I still keep a keen interest in derm developments such as the release of cytopoint, our new monoclonal antibody against IL31.
